Open AccessA Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
Author(s) -
Guangshao Cao,
Yuyan Liu,
Lupeng Li,
Xiaoyang Zhao,
Ruiqing Liu,
Jian Liu,
Jianwen Liu,
Huicun Cao
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s308097
Subject(s) - medicine , radiofrequency ablation , hepatocellular carcinoma , incidence (geometry) , gastroenterology , nausea , adverse effect , vomiting , constipation , hazard ratio , ablation , confidence interval , physics , optics
There has been very limited investigation regarding the comparison of adverse events (AEs) among radiofrequency ablation (RFA), conventional transarterial chemoembolization (cTACE), and drug-eluting bead TACE (DEB-TACE) in treating HCC patients; therefore, the present study aimed to resolve this issue.